Skip to content

Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study

Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01797692
Acronym
PROGE
Enrollment
74
Registered
2013-02-22
Start date
2013-01-31
Completion date
2015-02-28
Last updated
2015-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Population Control, Prostate Cancer Cured

Keywords

prostate cancer cured, aged patients

Brief summary

This is a multicenter pilot study, proposed for cases and controls 3 departments in France. Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are healthy subjects selected by lottery on voter list. Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

Detailed description

Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician. During this consultation, ADL, IADL and MMS questionnary will be completed. neurocognitif testing will be done.

Interventions

OTHERgeriatric assessment

A single geriatric assessment with a geriatrician was proposed to patients and to control population.

Sponsors

Centre Francois Baclesse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
75 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for patients: * Patients aged 75 years or more * Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years * Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer * Patients considered cured of prostate cancer (regardless of initial treatment) * Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric * Signature of consent * Affiliation to a social security system

Exclusion criteria

for patients: * Patients under 75 years * Patients with recurrent or metastatic * Persons deprived of liberty or under guardianship Inclusion Criteria for control population: * Male subjects * Subjects of 75 years or more * Subjects that do not have cancer or a history of cancer (except basal cell skin cancer) * Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics * Subjects who gave their written consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
impact of treatments10 years after treatment for cancer prostateThe main objective of this study is to evaluate the impact of treatments and their effects on the autonomy of patients over 75 years have been treated and cured for prostate cancer.

Secondary

MeasureTime frameDescription
Evaluate the anxiety of patients and controls10 years after treatment for cancer prostateEvaluate the anxiety of patients and controls
Assessing depression patients and controls10 years after treatments for cancer prostateAssessing depression patients and controls
Assess the nutritional status of patients and controls10 years after treatments for cancer prostateAssess the nutritional status of patients and controls

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026